Fredun Pharmaceuticals: microcap theme

Fredun Pharmaceuticals: microcap theme

• Fredun Pharmaceuticals Reports 61% YoY Growth in EBITDA to ₹39.33 Cr in H1 FY26
• Commenting on the financial performance Mr. Fredun Medhora, Managing Director, said, “Q2 FY26 was a strong quarter for Fredun, driven by consistent growth across our pharmaceutical and pet care verticals. Our domestic formulations segment continued to deliver solid performance through new product introductions and expanding institutional demand, while exports maintained steady traction. We have commenced expansion of our state-of-the-art manufacturing facility at Palghar to enhance capacity, improve operational efficiency, and support the growing demand across both domestic and international markets. The past few months have been pivotal in shaping Fredun’s position as a first mover in India’s organized pet healthcare space. The launch of Snacky Jain—India’s first Jain functional food for pets—received an overwhelming response, with the entire first batch sold out through pre-orders. Backed by robust capacity, strong retail partnerships, and growing presence across eight states, this launch reinforces our ethical and research-led approach to pet nutrition. Our acquisitions of Wagr.ai and One Pet Stop have expanded our footprint across nutrition, technology, and services—creating a truly connected and science-driven pet care ecosystem. This integrated approach positions us uniquely at the intersection of healthcare, nutrition, and technology in a market poised for exponential growth. We reported improved cash flows this quarter, driven by efficient execution and disciplined operations. Looking ahead, we aim to scale our operations, accelerate new product launches, and strengthen our digital-first platforms to enhance accessibility and experience for pet parents. With a clear strategy, strong execution, and first-mover advantage, we remain confident of sustaining our growth momentum and building long-term value for all”

FY24 PAT was Rs 15.6 Crores, up by 44.6% YoY

• FY24 revenues were up by 26.2% YoY to Rs 349 Crores
  
• Launched 250 products in FY24 under cosmeceuticals segment - Beauty Fred, a new mass market brand. This completes the product range, and is witnessing early signs of traction in the segment
  
• Launched around 45 branded Nutritional products across various targeted segmental class during FY24 and was able to achieve double digit sales. 
• Encouraged by the response, planning to launch the products across the western region in FY25. 
• In addition, will be introducing another 35-40 products during the year